Cardiovascular Medicine Book

Hypertension

Electrocardiogram

Hypotension

Hyperlipidemia

Coronary Artery Disease

Pericardial Disorders

Congestive Heart Failure

Examination

Inotrope

Obstetrics Chapter related topics

http://www.fpnotebook.com/

Esmolol

Aka: Esmolol, Esmolol Hydrochloride, Brevibloc
Advertisement
  1. See Also
    1. Beta Blocker
  2. Mechanism
    1. Selective Beta Blocker
  3. Indications
    1. Atrial Fibrillation Rate Control
    2. Emergent Hypertension Management
  4. Pharmacokinetics
    1. Half-life: 9 minutes
    2. Duration of action: 15-20 minutes
  5. Dosing: Intravenous
    1. Preparation: 2.5g (10 ml ampule) in 250 ml (10 mg/ml)
    2. Load: 250-500 ug/kg over 1 min (70 kg: 35 mg, 3.5 ml)
    3. Infusion:
      1. Start 25-50 ug/kg/min IV (70 kg: 10 ml/h)
      2. Titrate up 25-50 ug/kg q5 min to max 300 ug/kg/min

Brevibloc (C0591189)

Concepts Organic Chemical (T109) , Pharmacologic Substance (T121)
MSH C036604
English Brevibloc, Baxter brand of esmolol hydrochloride, Boots brand of esmolol hydrochloride, Prasfarma brand of esmolol hydrochloride, Rhône-Poulenc Rorer brand of esmolol hydrochloride
Sources
Derived from the NIH UMLS (Unified Medical Language System)


Esmolol hydrochloride (C0700606)

Definition (NCI) The hydrochloride salt form of esmolol, a short and rapid-acting beta adrenergic antagonist belonging to the class II anti-arrhythmic drugs and devoid of intrinsic sympathomimetic activity. Esmolol hydrochloride competitively blocks beta-1 adrenergic receptors in cardiac muscle and reduces the contractility and cardiac rate of heart muscle, thereby decreasing cardiac output and myocardial oxygen demands. This agent also decreases sympathetic output centrally and blocks renin secretion. At higher doses, esmolol hydrochloride also blocks beta-2 receptors located in bronchial and vascular smooth muscle, thereby leading to smooth muscle relaxation.
Concepts Organic Chemical (T109) , Pharmacologic Substance (T121)
MSH C036604
SnomedCT 35318005, 318624002
English Esmolol HCl, 4-(2-Hydroxy-3-((1-methylethyl)amino)propoxy)benzenepropanoic Acid Methyl Ester HCl, (+-)-Methyl p-(2-hydroxy-3-(isopropylamino)propoxy)hydrocinnamate Hydrochloride, esmolol hydrochloride, Esmolol Hydrochloride, esmolol hydrochloride (medication), ESMOLOL HYDROCHLORIDE, Esmolol hydrochloride, Esmolol hydrochloride product, Esmolol hydrochloride (substance), Esmolol hydrochloride product (product), Esmolol hydrochloride product (substance)
Spanish producto con clorhidrato de esmolol (producto), clorhidrato de esmolol (producto), producto con clorhidrato de esmolol, clorhidrato de esmolol (sustancia), clorhidrato de esmolol, producto (producto), clorhidrato de esmolol, producto, clorhidrato de esmolol
Sources
Derived from the NIH UMLS (Unified Medical Language System)


Navigation Tree